Entia

07/10/2021

Entia has raised $12 million in a funding round led by UK growth capital investor BGF, with participation from existing seed investors, including Parkwalk and Sussex Place Ventures. The funding will be used to develop and launch a virtual oncology solution that will allow patients to perform their own blood tests at home, making it possible for remote healthcare teams to monitor and help manage the haematological toxicity of cancer treatment.

Since founding the company in 2015, we have built partnerships with leading institutions, such as The Christie NHS Foundation Trust, to pioneer the introduction of solutions.

Making healthcare services available remotely has become a priority for health systems and pharmaceutical companies. We have recently announced a partnership with Pfizer UK to make our virtual monitoring service available in the UK for metastatic breast cancer patients in 2022, following regulatory approval.

Read more now:

Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised £9 million earlier in the year in a funding

12/12/2020

In 2018, Health Bridges International, Inc. partnered with Entia and Lucky Iron Fish on a pilot project to develop a long-term solution for iron deficiency anaemia in developing Peruvian communities.

Rates of IDA are particularly high among children in some areas of Peru – over 60% in some communities.

The anaemia itself is relatively easy to resolve – but past attempts revealed that the approach needs to be holistic and an understanding of the social and economic factors that contribute to knowledge uptake and treatment adherence is critical to success.

Speaking of the project, Dr Wayne Centrone, Founder and President of Health Bridges International commented:

“Entia represented a critical part. If people don’t know their information, how can they be actionable about it in their lives?”

Read our latest case study and discover more about how the combination of Entia’s anaemia management device, Aptus, alongside ’s IDA treatment, empowered these communities to take control of their health.

https://www.entia.co/case-studies/a-model-for-change-treating-paediatric-anaemia-in-the-high-mountains-of-peru

04/12/2020

In the country of Peru, anaemia rates exceed 60% among children in some areas - making it more prevalent than malnutrition.

While the treatment of iron deficiency anaemia is relatively simple, it does require a holistic approach that focuses on both prevention and treatment as well as an understanding of the social and economic constraints that influence treatment uptake.

To achieve this, Health Bridges International (.org) partnered with Entia and Lucky Iron Fish () to create a solution to this multifaceted problem.

By deploying the Aptus, a point-of-care test providing almost immediate haemoglobin measurements, the efficacy of the treatment being trialled for iron deficiency anaemia could be conveniently evaluated on an ongoing basis.

Hear more about this project in our latest case study:

https://www.entia.co/case-studies/a-model-for-change-treating-paediatric-anaemia-in-the-high-mountains-of-peru

04/12/2020

In the country of Peru, anaemia rates exceed 60% among children in some areas - making it more prevalent than malnutrition.

While the treatment of iron deficiency anaemia is relatively simple, it does require a holistic approach that focuses on both prevention and treatment as well as an understanding of the social and economic constraints that influence treatment uptake.

To achieve this, Health Bridges International, Inc. partnered with Entia and Lucky Iron Fish to create a solution to this multifaceted problem.

By deploying the Aptus, a point-of-care test providing almost immediate haemoglobin measurements - the efficacy of the treatment being trialled for iron deficiency anaemia could be conveniently evaluated on an ongoing basis.

Hear more about this project in our latest case study 👇

https://www.entia.co/case-studies/a-model-for-change-treating-paediatric-anaemia-in-the-high-mountains-of-peru

13/09/2020

Healthcare professionals are being challenged to develop high-quality, efficient and cost-effective clinical pathways for patient care, all whilst dealing with increased demands during the height of the pandemic.

In a recent ‘Letter to the Editor’ by Hull University Teaching Hospitals NHS Trust in the Clinical Kidney Journal, Dr. Richard Bodington from the NHS discusses how working with Entia lead to the deployment of Luma to patients, the world’s first home haemoglobin monitoring solution.

You can see the full piece, here!

11/09/2020

Coutts, the prestigious UK private bank, has named Entia one of four firms that are forging the future of healthcare.

It’s an honour to be featured as part of this selection of innovative med-tech companies!

Read the full article, here 👇

https://bit.ly/2EJ7YMg

Meet four of the firms forging the future of health care with help from our clients

18/08/2020

Our recent project in partnership with Hull University Teaching Hospitals NHS Trust has also been covered by AT Today.

We are honoured that our home monitoring device, Luma will become a pivotal part in keeping vulnerable patients safe during this pandemic.

You can read the full article, here:

http://attoday.co.uk/nhs-partnership-deploys-essential-home-monitoring-solutions-to-patients-who-are-shielding/?fbclid=IwAR1kYgETSzgZejgSmufA6GtmvW6GzLuw3VNN9iWO9B7QlLykLmwBACuuqts

Entia has partnered with Hull University Teaching Hospitals NHS Trust to deploy home monitoring solutions to patients who are currently shielding.

13/08/2020

Our recent venture is in the news! 🗞

Our recent partnership to secure home monitoring solutions for at risk patients during COVID-19 with Hull University Teaching Hospitals NHS Trust has been covered by Med-Tech Innovation.

You can read the full article, here 👇

https://www.med-technews.com/news/monitoring-firm-and-nhs-trust-launch-partnership-for-those-s/

Home monitoring specialists Entia has partnered with Hull University Teaching Hospitals NHS Trust to deploy monitoring technology to patients with chronic kidney disease who are currently shielding.

30/07/2020

With the ability to optimise resources and direct time to more patients, the benefits of home monitoring are significant for healthcare professionals. 👨‍⚕️

But for the patient, it can be life-changing!

Our latest blog highlights how home monitoring can keep you safe, whilst aiding your emotional and physical health. 👇

https://lnkd.in/dnR2_yR

The emotional and physical benefits of monitoring life changing conditions, such as cancer, from home

24/07/2020

Although lockdown has started to loosen for most, many are still shielding!

This period has been particularly challenging for those living with conditions that leave them vulnerable, and leaving their homes for hospital appointments puts them at greater risk. 👨‍⚕️

How can patients stay safe while undergoing routine testing...? 👇

https://lnkd.in/eKNtuFt

Let’s Talk About Routine Testing During Quarantine22 APR 2020 With the healthcare system currently facing the biggest challenge our generation has ever seen due to COVID-19 – what does this mean for patients living with long-term conditions such as Iron deficiency Anaemia and Cancer who require ...